US, Spain Track Cruise Passengers After Hantavirus Scare

Health agencies in the United States and Spain are activating targeted monitoring and contact‑tracing protocols for cruise passengers and air travelers after a deadly outbreak of Andes hantavirus on the Dutch‑flagged expedition vessel MV Hondius, a multi‑country incident that now links South America, Africa and Europe and is drawing intense scrutiny from global travelers.

From Ushuaia to the Atlantic: How a Niche Cruise Sparked Global Alerts

Publicly available information indicates that the MV Hondius departed Ushuaia, Argentina, on 1 April 2026 for an “Atlantic Odyssey” voyage that combined Antarctic and sub‑Antarctic stops with remote islands in the South Atlantic before heading toward Africa and Europe. The itinerary placed passengers in regions where the rodent‑borne Andes strain of hantavirus is known to circulate on land.

Reports compiled by the World Health Organization and national health agencies describe how several passengers developed severe respiratory illness over subsequent weeks, with at least three deaths and additional critical cases now linked to the voyage. One British passenger was evacuated to South Africa after developing respiratory distress, where testing confirmed infection with Andes hantavirus.

As the outbreak came into focus in early May, media coverage from outlets in Europe, Africa and Latin America traced a complex chain of movements involving passengers who disembarked or were medically evacuated to South Africa, the Netherlands and other countries. The ship itself has been diverted toward Spain’s Canary Islands for disembarkation and further medical follow‑up under Spanish oversight.

By the second week of May, summary tallies referenced by the World Health Organization and regional scientific assessments pointed to eight laboratory‑confirmed cases of Andes virus infection associated with the cruise, including three fatalities and one patient in critical condition, alongside additional suspected infections under investigation.

United States Ramps Up Monitoring for Returning Passengers

Guidance documents made public by the US Centers for Disease Control and Prevention describe a focused effort to identify, notify and monitor individuals who may have been exposed to Andes hantavirus during the MV Hondius voyage or on connecting flights involving infected travelers. The CDC framework emphasizes rapid contact identification, symptom monitoring and clear communication for people in the United States who were on board or seated near confirmed cases during air travel.

According to this guidance, exposed travelers are being advised to self‑monitor for signs of hantavirus pulmonary syndrome, including fever, muscle aches and shortness of breath, for several weeks after their last potential exposure. The incubation period for Andes virus can be prolonged compared with many respiratory infections, which means the period of concern extends well beyond the cruise’s early April departure.

The same documents outline tiers of risk based on proximity and duration of contact, with higher‑risk contacts potentially subject to active follow‑up from health departments, such as regular check‑ins to assess symptoms. Testing is generally reserved for individuals who become ill, reflecting the absence of a routine screening test for people who are well but may have been exposed.

For American travelers who joined or left the vessel through South American gateways, or who transited South Africa and European hubs on the way home, this approach aims to catch early signs of illness while avoiding unnecessary disruption for the vast majority who are unlikely to become sick.

Spain Prepares for Canary Islands Arrival and European Follow‑Up

Spanish and European public‑health briefings indicate that Spain is preparing to receive the MV Hondius in the Canary Islands, where remaining passengers are expected to disembark under controlled conditions. National media in Spain report that at least a small group of Spanish nationals is on board, alongside citizens of multiple other countries who will later continue on to mainland Europe or onward international flights.

European scientific advice issued for health professionals in the EU and European Economic Area describes a coordinated strategy to classify and manage contacts once passengers step ashore. This includes criteria for identifying close contacts based on cabin sharing, prolonged face‑to‑face interaction or shared activities in confined spaces, which may carry a higher theoretical risk if person‑to‑person transmission of Andes virus occurred.

Information shared by Argentinian and European authorities also notes that Argentina is sending Andes virus genetic material and diagnostic tools to laboratories in Spain and several partner countries, aimed at speeding up confirmation of suspected cases. This technical cooperation reflects the likelihood that initial exposure occurred in South America before boarding, even though clinical illness surfaced during the Atlantic leg of the cruise.

For travelers already in Spain or planning onward trips through the country, the public‑health messaging consistently stresses that the broader risk to the community is considered low, while underscoring the importance of rapid medical evaluation if compatible symptoms develop after known exposure.

What Global Travelers Need to Know About Andes Hantavirus

Andes hantavirus is a rare but often severe infection primarily associated with certain rodent species in Argentina and neighboring parts of South America. Publicly accessible summaries from the World Health Organization and the US Centers for Disease Control and Prevention explain that people are typically infected by breathing in virus‑containing particles from rodent urine, droppings or saliva in enclosed or poorly ventilated spaces.

The form of disease most relevant to this outbreak is hantavirus pulmonary syndrome, which often begins with non‑specific symptoms such as fever, fatigue and muscle pain, followed by a rapid progression to coughing and severe shortness of breath as the lungs fill with fluid. Reported fatality rates for Andes hantavirus infections are substantially higher than those associated with many familiar respiratory viruses.

Unlike other hantaviruses, the Andes strain has documented instances of limited person‑to‑person transmission, usually in settings involving close, prolonged contact with a symptomatic individual, such as within households or intimate partnerships. Current assessments stress that casual contact in public places is not considered a major driver of spread, and there is no evidence of widespread community transmission linked to the MV Hondius incident.

There is no widely available vaccine or specific antiviral treatment for Andes hantavirus at this time. Clinical management instead focuses on early recognition, supportive care and intensive respiratory support for patients who develop severe lung involvement. This is one reason the current monitoring operations in the United States, Spain and other countries are placing such emphasis on awareness and rapid triage for recently exposed travelers.

Practical Guidance for Travelers Linked to Argentina, South Africa and Beyond

For travelers who were on the MV Hondius, who shared cabins or activities with known cases, or who sat close to infected passengers on flights connecting through South Africa, Europe or the United States, expert guidance recommends a heightened level of self‑awareness for at least six weeks after the last possible exposure. Symptoms such as persistent fever, unexplained fatigue, muscle aches, cough or difficulty breathing warrant prompt medical attention and disclosure of recent travel history.

Travelers planning trips to Argentina and other areas where Andes hantavirus circulates are being urged by public health advisories to minimize contact with rodents and rodent habitats. Practical steps include avoiding sleeping or storing luggage in spaces with visible rodent activity, keeping food in sealed containers, and favoring reputable accommodations and tour operators that maintain strict sanitation standards in rural or wildlife‑rich regions.

For those transiting major hubs in South Africa, Spain or other countries involved in the current response, the overall risk remains low. Screening measures at airports and ports are focused on identifying obviously ill passengers rather than restricting routine travel. Nevertheless, travelers with underlying health conditions or upcoming voyages that mirror remote expedition itineraries may wish to review their plans with a healthcare professional familiar with travel medicine.

More broadly, the MV Hondius outbreak highlights how highly specialized itineraries that link remote parts of Argentina, sub‑Antarctic environments, South Atlantic islands and African or European ports can create complex exposure networks. For international travelers, staying informed about evolving guidance, keeping records of routes and cabin numbers, and promptly responding to any contact notifications have become important parts of responsible long‑distance travel in the wake of this rare but closely watched hantavirus incident.